Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atherogenics Inc
Original Assignee
Atherogenics, Inc.
Patricia K. Somers
Lee K. Hoong
Charles Q. Meng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atherogenics, Inc., Patricia K. Somers, Lee K. Hoong, Charles Q. MengfiledCriticalAtherogenics, Inc.
Priority claimed from CA002289851Aexternal-prioritypatent/CA2289851C/fr
Publication of CA2562992A1publicationCriticalpatent/CA2562992A1/fr
Application grantedgrantedCritical
Publication of CA2562992CpublicationCriticalpatent/CA2562992C/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
CA2562992A1997-05-141998-05-14Analogues du probucol et leur utilisation en tant qu'inhibiteurs anti-inflammatoires de vcam-1
Expired - Fee RelatedCA2562992C
(fr)
Asociación de inhibidores de la HMG-CoA reductasa atorvastatina o simvastatina con un inhibidor de la fosfodiesterasa 4, tal como roflumilast para el tratamiento de enfermedades pulmonares inflamatorias